Powder: -20°C for 3 years
In solvent: -80°C for 2 years
BMS-817399 is an orally active antagonist of CCR1 with IC50s of binding affinity and chemotaxis inhibition potencies and can be used in studies about rheumatoid arthritis.
Description | BMS-817399 is an orally active antagonist of CCR1 with IC50s of binding affinity and chemotaxis inhibition potencies and can be used in studies about rheumatoid arthritis. |
Targets&IC50 | CCR1:1 nM (IC50) |
Synonyms | BMS817399 |
Molecular Weight | 454 |
Formula | C23H36ClN3O4 |
CAS No. | 1202400-18-7 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 55 mg/mL (121.14 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMS-817399 1202400-18-7 Immunology/Inflammation Microbiology/Virology CCR BMS 817399 BMS817399 Inhibitor inhibitor inhibit